☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
minghui pharmaceutical
Minghui Pharmaceutical Reports Topline Data from P-III Study of Tofacitinib Etocomil (MH004) Ointment for Atopic Dermatitis
December 2, 2024
Minghui Pharmaceutical Reports Initial Data from P-I Study of MHB039A for R/R Solid Tumors
November 6, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.
